Stay updated on Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedA site-wide notice about government funding lapse affecting data currency was added, and the page footer shows Revision: v3.4.1 replacing v3.4.0.SummaryDifference0.4%

- Check13 days agoChange DetectedThe page adds a glossary display and updates several metadata labels (e.g., capitalization in 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), along with a new revision label 'v3.4.0'. Older labels such as 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were removed.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.3.4 was released, replacing v3.3.3. This appears to be a backend/format update without changes to the study details.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded a consolidated Locations section listing study sites (California, Colorado, Florida, Illinois, Kentucky, North Carolina, and Texas) and removed the previous per-state location subsections. Updated the page revision note to v3.3.3.SummaryDifference0.8%

- Check77 days agoChange DetectedThe Publications section wording was updated to say publications are automatically filled from PubMed, replacing the previous phrasing. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check84 days agoChange DetectedThe government funding status banner was removed from the page. Core study details and links remain unchanged.SummaryDifference0.4%

Stay in the know with updates to Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.